The institutional landscape for Revelation Biosciences, Inc. (NASDAQ:REVB) includes 12 filers as of the latest reporting cycle ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 31 Dec, 2025 | 605,702 | 398,651 | 192.54% | $484,440.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 434,272 | 354,272 | 442.84% | $347,331.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 54,728 | 54,728 | 0.00% | $43,771.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 52,505 | 52,505 | 0.00% | $42,004.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 34,019 | 34,019 | 0.00% | $27,207.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 21,907 | 21,907 | 0.00% | $17,521.00 |
| HRT FINANCIAL LP | 31 Dec, 2025 | 15,320 | 15,320 | 0.00% | $12.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 11,319 | 11,319 | 0.00% | $9,053.00 |
| UBS Group AG | 31 Dec, 2025 | 724 | 722 | 36,100.00% | $579.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 47 | 33 | 235.71% | $38.00 |
| BNP Paribas Asset Management Holding S.A. | 31 Dec, 2025 | 38 | 38 | 0.00% | $0.00 |
| ROYAL BANK OF CANADA | 31 Dec, 2025 | 2 | 2 | 0.00% | $0.00 |